IC
MJN

Intersect Capital’s Mead Johnson Nutrition Company MJN Stock Holding History

Intersect Capital’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-479
Closed -$46K – 435
2015
Q1 		$46K Hold
479
– – 0.04% 188
2014
Q4 		$48K Buy
+479
New +$47.7K 0.04% 190

Other funds holding MJN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Intersect Capital's MJN Position: Q2 2015 in Review

Intersect Capital sold out of Mead Johnson Nutrition Company (MJN) in Q2 2015, closing a stake of 479 shares — an estimated $46K sold.

Intersect Capital first reported a position in MJN in Q4 2014 and held it in 2 quarters. The position peaked at $48K in Q4 2014. 543 funds tracked by Wall St. Rank hold MJN as of Q2 2015.

  • Intersect Capital reported no remaining Mead Johnson Nutrition Company position as of Q2 2015 after selling out during the quarter.
  • Intersect Capital sold 479 Mead Johnson Nutrition Company shares in Q2 2015, an estimated $46K.
  • Intersect Capital first reported a position in Mead Johnson Nutrition Company in Q4 2014 and held it in 2 quarters.
  • Intersect Capital's Mead Johnson Nutrition Company position peaked at $48K in Q4 2014.
  • 543 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2015.

Based on Intersect Capital's 13F filing for Q2 2015, filed 3 Aug 2015.